Autopsy report · NCT01442428

Paradoxical Tuberculosis Immune Reconstitution Inflammatory Syndrome (TB-IRIS) Treatment Trial

Cause of deathDrug or device supply, also regulatory or ethics Automatic label, confidence 0.6, unverified. How labels are made.

“2011 Thailand flooding led to loss of GMP pharmacy, project delays, and further regulatory challenges.”

The sponsor’s own words in the registry.

Life of this trial

Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status: Withdrawn
Phase: Phase 2, Phase 3
Sponsor: University of Minnesota
Sponsor type: University, hospital or other
Conditions: Immune Reconstitution Inflammatory Syndrome; Immune Reconstitution Syndrome; Tuberculosis; HIV-infection/Aids
Interventions: Dexamethasone; Atorvastatin; Naproxen; Placebo
Participants: 0
Sites: 3
Countries: Thailand

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.